LMAT 87.26 ▼ -0.14% Live Trading Data - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    LeMaitre Vascular Inc.

    NASDAQ: LMAT · Real-Time Price · USD
    87.26
    -0.12 (-0.14%)
    At close: Oct 15, 2025, 3:59 PM
    87.26
    0.00%
    After-hours: Oct 15, 2025, 04:20 PM EDT
    -0.14%
    Bid 85.15
    Market Cap 1.98B
    Revenue (ttm) 234.64M
    Net Income (ttm) 47.12M
    EPS (ttm) 2.05
    PE Ratio (ttm) 42.57
    Forward PE 34.4
    Analyst Buy
    Dividends $0.76
    Ask 96.8
    Volume 84,033
    Avg. Volume (20D) 169,181
    Open 87.12
    Previous Close 87.38
    Day's Range 86.24 - 87.94
    52-Week Range 71.42 - 109.58
    Beta 0.77
    Ex-Dividend Date Aug 21, 2025

    About LMAT

    undefined

    [Read more]
    Industry n/a
    Sector n/a
    IPO Date n/a
    Employees NaN
    Stock Exchange n/a
    Ticker Symbol LMAT
    Website n/a
    Full Company Profile

    Analyst Forecast

    According to 0 analyst ratings, the average rating for LMAT stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

    Stock Forecasts

    Next Earnings Release

    LeMaitre Vascular Inc. is scheduled to release its earnings on Nov 6, 2025, after market closes.
    Analysts project revenue of ... Unlock content with Pro Subscription
    2 months ago
    +8.91%
    LeMaitre Vascular shares are trading higher after ... Unlock content with Pro Subscription
    5 months ago
    -12.79%
    LeMatire Vascular shares are trading lower after the company reported Q1 EPS guidance below estimates and lowered its FY25 EPS guidance.
    news image

    4 weeks ago · seekingalpha.com

    LeMaitre Vascular: Investment Debate Remains In Place

    LeMaitre Vascular remains a long-term compounder, delivering strong Q2 results with 15% sales growth, robust margins, and increased dividends. LMAT's investment thesis is supported by pricing power, a...

    news image

    1 month ago · zacks.com

    Is LeMaitre (LMAT) a Solid Growth Stock? 3 Reasons to Think "Yes"

    LeMaitre (LMAT) possesses solid growth attributes, which could help it handily outperform the market.

    news image

    1 month ago · seekingalpha.com

    Trump Wins

    I like that Telus is deleveraging, and I'll be following how much revenue the co-location of cell towers could bring to the table now that Telus's tower network is half-owned by a third party. I see l...

    news image

    2 months ago · zacks.com

    LeMaitre (LMAT) is an Incredible Growth Stock: 3 Reasons Why

    LeMaitre (LMAT) is well positioned to outperform the market, as it exhibits above-average growth in financials.

    news image

    2 months ago · fool.com

    LeMaitre (LMAT) Q2 Revenue Jumps 15%

    LeMaitre (LMAT) Q2 Revenue Jumps 15%

    news image

    2 months ago · seekingalpha.com

    LeMaitre Vascular, Inc. (LMAT) Q2 2025 Earnings Call Transcript

    LeMaitre Vascular, Inc. (NASDAQ:LMAT ) Q2 2025 Earnings Conference Call August 5, 2025 5:00 PM ET Company Participants David B. Roberts - President & Director Dorian LeBlanc - Chief Financial Officer ...

    news image

    2 months ago · zacks.com

    LeMaitre Vascular (LMAT) Beats Q2 Earnings and Revenue Estimates

    LeMaitre Vascular (LMAT) came out with quarterly earnings of $0.6 per share, beating the Zacks Consensus Estimate of $0.57 per share. This compares to earnings of $0.52 per share a year ago.

    news image

    2 months ago · zacks.com

    PAHC vs. LMAT: Which Stock Should Value Investors Buy Now?

    Investors with an interest in Medical - Products stocks have likely encountered both Phibro Animal Health (PAHC) and LeMaitre Vascular (LMAT). But which of these two stocks presents investors with the...

    Add to Watchlist